Dr Eyal Walter, MD in Ann Arbor, MI - Ophthalmology

Dr Eyal Walter, MD is a Ophthalmology - Neuro-ophthalmology physician based in Ann Arbor, Michigan. Dr Eyal Walter is licensed to practice in Michigan (license number 4301113990) and his current practice location is 1000 Wall St, Ann Arbor, Michigan. He can be reached at his office (for appointments etc.) via phone at (734) 763-9147.

NPI number for Dr Eyal Walter is 1447758099 and his current mailing address is 1072 Island Drive Ct Apt 103, Ann Arbor, Michigan. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1447758099.

Contact Information

	Dr Eyal Walter, MD
	1000 Wall St, Ann Arbor, MI 48105-1912
	(734) 763-9147
	Not Available

Physician's Profile

Full Name	Dr Eyal Walter
Gender	Male
Speciality	Ophthalmology - Neuro-ophthalmology
Location	1000 Wall St, Ann Arbor, Michigan
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1447758099
Provider Enumeration Date: 01/29/2018
Last Update Date: 01/29/2018

Medical Identifiers

Medical identifiers for Dr Eyal Walter such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1447758099	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207WX0109X	Ophthalmology - Neuro-ophthalmology	4301113990 (Michigan)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Eyal Walter is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Eyal Walter, MD 1072 Island Drive Ct Apt 103, Ann Arbor, MI 48105-2077 Ph: (734) 709-7666	Dr Eyal Walter, MD 1000 Wall St, Ann Arbor, MI 48105-1912 Ph: (734) 763-9147

News Archive

InfraReDx receives 510(k) clearance to market LipiScan IVUS Coronary Imaging System

InfraReDx, Inc., a medical device company developing intelligent cardiovascular diagnostic imaging technologies, today announced that it has received 510(k) clearance from the United States Food and Drug Administration to market the LipiScan IVUS Coronary Imaging System. LipiScan IVUS is the first cardiac catheter to combine intravascular ultrasound and near-infrared spectroscopy to help cardiologists identify and characterize the plaques that complicate stenting and are associated with acute coronary events.

Antimicrobial stewardship to ambulatory setting should include continued feedback to clinicians

The initial benefits of an outpatient antimicrobial stewardship intervention designed to reduce the rate of inappropriate antibiotic prescriptions were lost after discontinuation of audit and feedback to clinicians, according to a study published in JAMA. The study is being released early online to coincide with the IDWeek 2014 meeting.

Siemens Healthcare announces series of flexible financing solutions for healthcare providers

Siemens Healthcare today announced a series of flexible financing solutions to help healthcare providers pursue meaningful use objectives and meet deadlines defined within the HITECH provision of the American Recovery and Reinvestment Act (ARRA).

Preliminary estimation of contaminants and aromatic substances in diapers

The report "Sécurité des couches pour bébé", published by the French Agency for Food, Environmental and Occupational Health & Safety, deals with hazardous substances in disposable panty diapers.

Cumberland Pharmaceuticals submits Acetadote sNDA for non-acetaminophen acute liver failure

Cumberland Pharmaceuticals Inc. has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration for the use of Acetadote® (acetylcysteine) Injection in patients with non-acetaminophen acute liver failure. Acetadote was launched by Cumberland in 2004 as the first U.S.-approved injectable drug to treat acetaminophen overdose.

Ophthalmology Doctors in Ann Arbor, MI

Said M Issa, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2900 Golfside Dr, Suite 2, Ann Arbor, MI 48108 Phone: 313-724-2733 Fax: 313-724-2456
Jill Elizabeth Bixler, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1000 Wall Street, Ann Arbor, MI 48105 Phone: 734-764-4190
Paul P Lee, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1000 Wall Street, Ann Arbor, MI 48105 Phone: 734-764-4190
Monte Anthony Delmonte, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1000 Wall St, Ann Arbor, MI 48105 Phone: 734-764-4190
Denise Ann-marie John, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1000 Wall Street, Ann Arbor, MI 48105 Phone: 734-764-4190
Brittany A Simmons, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1000 Wall St, Ann Arbor, MI 48105 Phone: 734-764-4190
Alexander Valentine, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1000 Wall St, Ann Arbor, MI 48105 Phone: 734-763-8122

Dr Eyal Walter, MD - Ophthalmology in Ann Arbor, MI